[TOVX] QoQ Quarter Result on 30-Sep-2024 [#Q3]

Stock
[TOVX] Theriva Biologics, Inc.
Announcement Date
30-Sep-2024
Financial Year
2024
Quarter
30-Sep-2024 [#Q3]
Profit Trend
QoQ- 7.09%
YoY- -133.91%
Quarter Report
TOVX's Result
TOVX's Financial Summary
View:
Show?
Quarter Result
30/09/24 30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 CAGR
Revenue 0 0 0 758 0 0 0 -
PBT -7,726 -8,316 -5,165 -5,909 -3,830 -5,443 -4,808 37.07%
Tax 0 0 -4 -424 -527 -359 -330 -
NP -7,726 -8,316 -5,165 -5,485 -3,303 -5,084 -4,478 43.70%
Tax Rate - - - - - - - -
Total Cost 7,726 8,316 5,165 6,243 3,303 5,084 4,478 43.70%
Ratio Analysis
30/09/24 30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 CAGR
NP Margin 0.00 0.00 0.00 -723.61 0.00 0.00 0.00 -
Per Share
30/09/24 30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 CAGR
EPS -6.81 -0.43 -7.53 -8.00 -4.85 -8.38 -7.40 -5.37%
EPS Diluted -6.81 -10.72 -7.53 -8.00 -4.85 -8.38 -7.40 -5.37%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.